5:01 PM ET
8-K
Executive Compensation
Gain Therapeutics Executive Compensation
Gain Therapeutics appointed Jeanette Weidner as Vice President, Finance, and principal financial and accounting officer, effective October 28, 2026. Her compensation package includes an annual base salary of $275,000, a target annual cash bonus of 35%, and an option to purchase 130,000 shares of common stock vesting over four years.